{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:39:42Z","timestamp":1788435582651,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Actin-related protein 2\/3 complex subunit 2 (ARPC2) plays a fundamental role in actin filament nucleation and is critical for tumor cell migration and invasion. However, its abnormal expression, clinical significance, and biological function in human pan-cancer have been poorly explored. Thus, we focused on ARPC2 as an entry point for identifying novel pan-cancer prognostic biomarkers.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) databases were used to assess the differential expression of ARPC2 in pan-cancer. The Human Protein Atlas was used for the tissue\/cell-specific expression analysis of ARPC2. The genetic alteration information of ARPC2 was obtained from the cBioPortal database and the GSCALite platform. The prognostic value of ARPC2 was explored in pan-cancer using Cox regression and Kaplan\u2013Meier analyses. Spearman correlation analysis was performed to investigate the relationship between ARPC2 expression and tumor mutational burden (TMB), DNA methyltransferases, microsatellite instability (MSI), immune-related genes, and mismatch repairs (MMRs). The ESTIMATE and CIBERSORT algorithms were used to evaluate the association between ARPC2 expression and the tumor microenvironment (TME) and immune infiltrating cells. We also conducted differential expression analysis of ARPC2 in hepatocellular carcinoma (HCC) tissues and cell lines using qPCR, western blotting, and immunohistochemistry and explored its role in tumor proliferation, migration, and invasion of HCC cells.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> ARPC2 expression was significantly upregulated in multiple tumor types and significantly correlated with worse prognosis and higher clinicopathological stage. Genetic alterations and DNA methylation in tumor tissues may contribute to the aberrant expression of ARPC2. ARPC2 expression was significantly correlated with the tumor microenvironment (TME), infiltrating immune cells, TMB, microsatellite instability (MSI), and immune checkpoint-related genes in certain cancer types. In this experimental study, we found that the expression of ARPC2 was dramatically upregulated in HCC tissues and cell lines compared to adjacent liver tissues and normal liver cell lines. Functionally, ARPC2 silencing in HCC cells significantly inhibited cell proliferation, migration, and invasion, while the overexpression of ARPC2 promotes tumor proliferation, migration, and invasion.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> ARPC2 is a promising prognostic and immunological biomarker for multiple tumor types and is likely to play an important role in HCC progression and metastasis.<\/jats:p>","DOI":"10.3389\/fcell.2022.896080","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T08:14:52Z","timestamp":1654503292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion"],"prefix":"10.3389","volume":"10","author":[{"given":"Shenglan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA Mismatch Repair in Cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e000442","DOI":"10.1136\/esmoopen-2018-000442","article-title":"Implementing TMB Measurement in Clinical Practice: Considerations on Assay Requirements","volume":"4","author":"B\u00fcttner","year":"2019","journal-title":"ESMO Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41571-019-0173-9","article-title":"Comparing and Contrasting Predictive Biomarkers for Immunotherapy and Targeted Therapy of NSCLC","volume":"16","author":"Camidge","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.3892\/or.2019.7113","article-title":"ARPC2 Promotes Breast Cancer Proliferation and Metastasis","volume":"41","author":"Cheng","year":"2019","journal-title":"Oncol. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1111\/cas.14205","article-title":"Pimozide Suppresses Cancer Cell Migration and Tumor Metastasis through Binding to ARPC2, a Subunit of the Arp2\/3 Complex","volume":"110","author":"Choi","year":"2019","journal-title":"Cancer Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"20220","DOI":"10.3390\/ijms141020220","article-title":"Proteomic Analysis Identifies an NADPH Oxidase 1 (Nox1)-Mediated Role for Actin-Related Protein 2\/3 Complex Subunit 2 (ARPC2) in Promoting Smooth Muscle Cell Migration","volume":"14","author":"Ghouleh","year":"2013","journal-title":"Ijms"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-020-00743-4","article-title":"MHC-I Genotype and Tumor Mutational Burden Predict Response to Immunotherapy","volume":"12","author":"Goodman","year":"2020","journal-title":"Genome Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the Percentage of US Patients with Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","article-title":"Classification and Characterization of Microsatellite Instability across 18 Cancer Types","volume":"22","author":"Hause","year":"2016","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 Challenges in Cancer Immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic Immunity in Cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"690151","DOI":"10.3389\/fmolb.2021.690151","article-title":"Identification of Arp2\/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma","volume":"8","author":"Huang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","article-title":"The Biology of Hepatocellular Carcinoma: Implications for Genomic and Immune Therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"Mol. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1083\/jcb.201101035","article-title":"Measurements of Spatiotemporal Changes in G-Actin Concentration Reveal its Effect on Stimulus-Induced Actin Assembly and Lamellipodium Extension","volume":"193","author":"Kiuchi","year":"2011","journal-title":"J. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of Immune Microenvironment in Hepatocellular Carcinoma and its Additional Impact on Histological and Molecular Classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1096\/fj.09-149328","article-title":"Glucose Restriction Can Extend Normal Cell Lifespan and Impair Precancerous Cell Growth through Epigenetic Control of hTERT and P16 Expression","volume":"24","author":"Li","year":"2010","journal-title":"FASEB J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a Web Server for Gene Set Cancer Analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High Tumor Mutation Burden Fails to Predict Immune Checkpoint Blockade Response across All Cancer Types","volume":"32","author":"McGrail","year":"2021","journal-title":"Ann. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1152\/physrev.00006.2017","article-title":"The Arp2\/3 Regulatory System and its Deregulation in Cancer","volume":"98","author":"Molinie","year":"2018","journal-title":"Physiol. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring Immune-Checkpoint Blockade: Response Evaluation and Biomarker Development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B23","first-page":"45","article-title":"Silencing of the ARP2\/3 Complex Disturbs Pancreatic Cancer Cell Migration","volume":"33","author":"Rauhala","year":"2013","journal-title":"Anticancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer Immunology. Mutational Landscape Determines Sensitivity to PD-1 Blockade in Non-small Cell Lung Cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/s0140-6736(16)00561-4","article-title":"Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed Following Treatment with Platinum-Based Chemotherapy: a Single-Arm, Multicentre, Phase 2 Trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.devcel.2017.08.003","article-title":"Arp2\/3 Complex Is Required for Macrophage Integrin Functions but Is Dispensable for FcR Phagocytosis and In Vivo Motility","volume":"42","author":"Rotty","year":"2017","journal-title":"Dev. Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor Mutational Load Predicts Survival after Immunotherapy across Multiple Cancer Types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor Mutational Burden Is Predictive of Response to Immune Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3892\/ijo.2012.1390","article-title":"Actin-related Protein 2\/3 Complex Subunit 5 (ARPC5) Contributes to Cell Migration and Invasion and Is Directly Regulated by Tumor-Suppressive microRNA-133a in Head and Neck Squamous Cell Carcinoma","volume":"40","author":"Seki","year":"2012","journal-title":"Int. J. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12981","DOI":"10.1038\/srep12981","article-title":"Systems Biology Approach to Studying Proliferation-dependent Prognostic Subnetworks in Breast Cancer","volume":"5","author":"Song","year":"2015","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"615472","DOI":"10.3389\/fonc.2020.615472","article-title":"Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy","volume":"10","author":"Su","year":"2020","journal-title":"Front. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jcb.29136","article-title":"ARPC4 Promotes Bladder Cancer Cell Invasion and Is Associated with Lymph Node Metastasis","volume":"121","author":"Xu","year":"2020","journal-title":"J. Cell Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s00432-019-03053-4","article-title":"Correlations between Microsatellite Instability and the Biological Behaviour of Tumours","volume":"145","author":"Yang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bcp.2019.01.017","article-title":"Benproperine, an ARPC2 Inhibitor, Suppresses Cancer Cell Migration and Tumor Metastasis","volume":"163","author":"Yoon","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture from Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5432818","article-title":"Role of ARPC2 in Human Gastric Cancer","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8952","DOI":"10.1038\/s41598-017-08357-4","article-title":"Arp2\/3 Complex Controls T Cell Homeostasis by Maintaining Surface TCR Levels via Regulating TCR(+) Endosome Trafficking","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.896080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T08:14:56Z","timestamp":1654503296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.896080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":39,"alternative-id":["10.3389\/fcell.2022.896080"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.896080","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"article-number":"896080"}}